News | Radiation Therapy | April 01, 2016

Pyrexar Announces New Partnership to Bring Hyperthermia Cancer Therapy to Cuba

Distribution network will include Cuba, the West Indies, Panama and Venezuela

Pyrexar Medical, hyperthermia products, Cuba, West Indies, Clinitech Co. Ltd.

April 1, 2016 — Pyrexar Medical announced a new distribution partnership with Clinitech Co. Ltd., bringing Pyrexar’s hyperthermia technologies into Cuba, the West Indies, Panama and Venezuela.

Cancer deaths are high in Cuba at 138 per 100,000, according to World Life, an organization that tracks death causality throughout the world. Cuba cancer stats rank 31 in the world, slightly lower than the United Kingdom, and several points higher than the United States. According to a study in 2001-2003 by the National Cancer Registry, lung, prostate, throat and colon cancers had high incidence in men, while breast, cervix, lung and colon cancers were the most prevalent in women.

Clinitech will be providing sales and service for the Pyrexar family of superficial, interstitial and deep regional hyperthermia devices. Leading their team is Ross University School of Medicine Oncology Professor Kamal Malaker, M.D., Ph.D., who has successfully used hyperthermia technology in the treatment of cancer. “We are excited to bring this relatively under-explored, under-utilized, well-proven, life-saving technology to the region.” said Wazir Mohammed, Clinitech’s president.

The distribution territory includes: Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Bonaire, British Virgin Islands, Cayman Islands, Cuba, Curacao, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, Panama, Puerto Rico, Saba, St. Ecstasies, St Kitts & Nevis, St. Lucia, St. Maarten, St. Vincent. Suriname, Trinidad and Tobago, Turks and Caicos, U.S. Virgin Islands (St. Thomas, St. Croix and St John) and Venezuela.

For more information:

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America